In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Agile Therapeutics, Inc.. Trade Record

NASDAQ:AGRX Agile Therapeutics, Inc. stock gains 32.84% Exit Oct 16, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart AGRX Sep 20, 2017, priceSeries
About Agile Therapeutics, Inc.

Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
97.30
Entry Date
Sep 20, 2017
Entry Price
3.73
Sell Date
Oct 16, 2017
Sell Price
4.95
Net Gain
32.84%
Hold Time
18 Trading Days